Contact our office today to schedule a free consultation
Less common but more serious risks, including pancreatitis and gallbladder complications, are reviewed with you before treatment begins and are part of what your follow-up visits monitor for
for example, in SingleCare, less than 5% of Ozempic users reported cardiovascular side effects, including palpitations
According to the FDA-approved prescribing information, patients start at 0.25 mg once weekly for the first four weeks (a dose-initiation phase not intended for blood sugar control), then increase to therapeutic doses
Safety assessments included adverse events, hypoglycaemic episodes, vital signs, electrocardiogram, clinical laboratory assessments, physical examination and anti-icodec and anti-semaglutide antibodies